Can a patient with rheumatoid arthritis taking methotrexate (MTX) 25mg weekly take folic acid 3 times a week?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Folic Acid Dosing for Rheumatoid Arthritis Patients on Methotrexate

Yes, a patient with rheumatoid arthritis taking methotrexate 25mg weekly can take folic acid 3 times per week, though daily dosing (except on methotrexate day) is preferred and more commonly recommended. The minimum effective dose is at least 5 mg total per week, which can be achieved through various dosing schedules 1, 2, 3.

Recommended Folic Acid Dosing Strategies

The American College of Rheumatology strongly recommends prescribing at least 5 mg of folic acid per week for all patients on methotrexate therapy to reduce gastrointestinal and hepatic adverse effects without compromising efficacy 1, 4, 2.

Acceptable Dosing Schedules

  • Daily dosing (preferred): 1 mg daily for 6 days per week, skipping the day methotrexate is taken 2, 3
  • Weekly single dose: 5 mg once weekly, given at a distance from the methotrexate dose 3, 5
  • Three times weekly: This achieves the minimum 5 mg weekly threshold if giving approximately 1.5-2 mg per dose, though this is less commonly described in guidelines 3

The key principle is achieving at least 5 mg total per week regardless of the specific schedule chosen 1, 2, 3.

Why Folic Acid Should Not Be Given on Methotrexate Day

Folic acid should be given on all days except the day(s) when methotrexate is administered because folic acid may theoretically compete for cellular uptake of methotrexate when both are present simultaneously, potentially reducing therapeutic efficacy 2. The American Academy of Dermatology explicitly recommends avoiding folic acid on methotrexate administration days to prevent this potential interference 2.

Evidence for Efficacy and Safety

Meta-analysis of 788 RA patients demonstrated that folic acid supplementation:

  • Reduces gastrointestinal side effects by 26% relative risk (nausea, vomiting, abdominal pain) 6, 7
  • Reduces hepatotoxicity (elevated transaminases) by 77% relative risk 6, 7
  • Reduces patient withdrawal from methotrexate by 61% relative risk 6, 7
  • Does not reduce methotrexate efficacy when dosed at ≤5 mg/week 2, 6, 8

Dose Adjustment for Higher Methotrexate Doses

For patients on methotrexate >15 mg/week (such as your patient on 25 mg weekly), consider increasing folic acid to 7-10 mg weekly as the protective effect is most significant at lower methotrexate doses, and higher methotrexate doses may require proportionally more folate supplementation 2. The American College of Rheumatology notes that higher doses (7-35 mg/week) may be needed with higher methotrexate doses 2.

Practical Implementation for This Patient

For a patient on methotrexate 25 mg weekly taking folic acid 3 times per week:

  • Ensure the total weekly dose is at least 5 mg (ideally 7-10 mg given the high methotrexate dose) 1, 2
  • Avoid giving folic acid on the same day as methotrexate 2, 3
  • If giving 3 times weekly, space doses evenly (e.g., Monday, Wednesday, Friday if methotrexate is on Sunday) 2
  • Consider switching to daily dosing (1-2 mg daily, 6 days per week) for more consistent folate levels and potentially better toxicity reduction 2, 3

Common Pitfall to Avoid

Do not confuse routine folic acid supplementation with leucovorin (folinic acid) rescue therapy—leucovorin is reserved for methotrexate overdose or severe toxicity and should be administered immediately in those situations 2. For routine supplementation, folic acid is preferred over folinic acid due to lower cost and similar effectiveness, and folinic acid at doses >5 mg/week may actually reduce methotrexate efficacy 2, 5.

References

Guideline

Methotrexate Treatment Protocol for Rheumatoid Arthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Methotrexate and Folic Acid Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Methotrexate Prescribing Protocol for Rheumatoid Arthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis: A Systematic Review.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2019

Related Questions

When should folic acid supplements be given to patients with Rheumatoid Arthritis (RA) taking methotrexate weekly?
What is the treatment course of methotrexate (MTX) in Rheumatoid Arthritis (RA)?
What is the recommended dose of folic acid (Vitamin B9) for patients with Rheumatoid Arthritis (RA) taking methotrexate (Disease-Modifying Antirheumatic Drug, DMARD)?
What is the role of folic acid supplementation with methotrexate (MTX) in the treatment of rheumatoid arthritis (RA)?
What is the role of folinic acid (leucovorin) in patients with rheumatoid arthritis taking methotrexate?
What is the recommended stroke risk assessment and treatment for a patient with atrial fibrillation (AF), using the CHA2DS2-VASc (Congestive heart failure, Hypertension, Age 75 or older, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74, and Sex category) score?
What is the recommended stroke risk assessment and treatment for a patient with atrial fibrillation (AF), using the CHA2DS2-VASc (Congestive heart failure, Hypertension, Age 75 or older, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74, and Sex category) score?
What adjuvant systemic anti-HER2 (Trastuzumab) therapy is recommended for a patient with HER2-positive breast cancer who received neoadjuvant chemotherapy with Epirubicin, Cyclophosphamide, Docetaxel, and Herceptin (Trastuzumab) for 6 cycles, followed by mastectomy and axillary clearance, and was found to have residual invasive carcinoma grade 3?
What is the best course of action for a 44-year-old male with a slow, isolated decline in platelets (thrombocytopenia), stable red blood cell parameters, and improving white blood cell counts (leukocytes) over the past 4 months?
What causes anuria in a patient with a history of chronic alcoholism and a recent fever?
What is the best mood stabilizer to use with an antipsychotic in a patient with schizoaffective disorder, depressive type?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.